THE LATEST
Neuroblastoma Cancer Tumor in Children
Neuroblastoma is diagnosed in approximately 800 children in the United States each year. Ninety percent of cases occur in children under five years old, though the average age of diagnosis is between one and two years old. Still, because neuroblastomas form from fetal nerve cells, children as young as newborns can develop tumors, and neuroblastoma accounts for 50% of all cancer cases in infants.
Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities
In a landmark in pediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time, following the award of $1.4M to fund a new transatlantic clinical trial.
Rare Brain Tumors in Kids
Brain and spinal cord tumors, also known as central nervous system (CNS) tumors, are the most common type of solid tumors affecting children. Brain tumors make up about 15% of pediatric cancers, and are the second most commonly diagnosed cancer in children and now, the deadliest type of childhood cancer, ahead of leukemia.
Give Hope & Love
When the world entered the COVID-19 pandemic, all we needed was a little Hope & Love. We asked all of our young ambassadors to share their messages of hope to the world. A big thank you to all of the frontline workers who risked their lives during the world pandemic. From all of us at Solving Kids’ Cancer
Lace Up For Kids 2019: Childhood Cancer Awareness Month
The “Lace Up For Kids” campaign connected childhood cancer supporters and advocates both nationally and internationally. For the month of September, thousands of gold shoelaces were shipped and worn to help raise awareness for Childhood Cancer Awareness Month. Take a look at some of the people who participated – you may even recognize some influencers and celebrities!
Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma
Solving Kids’ Cancer, The Catherine Elizabeth Blair Memorial Foundation, and Wade’s Army awarded a $136,000 grant to support the novel immunotherapy clinical trial for childhood cancer. Researchers will use a humanized monoclonal antibody linked to IL2, known as hu14.18-IL2, which specifically targets neuroblastoma tumor cells and binds to them, while the IL2 activates NK cells…
Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany
Solving Kids’ Cancer has partnered with Band of Parents, Joining Against Cancer in Kids (J-A-C-K), and Solving Kids’ Cancer Europe, to advance new treatment options for children with neuroblastoma with the launch of a transatlantic Phase I clinical trial that is open for enrollment in the U.K. and will open soon in the US and Germany…
The Childhood Cancer STAR Act has been Signed!
The childhood cancer community and Solving Kids’ Cancer are grateful to our many champions in Congress, who successfully shepherded this bipartisan bill through both chambers. As a member of the Coalition Against Childhood Cancer (CAC2), we were proud to play a role in advancing and advocating for this legislation alongside CAC2’s advocacy partner coalition, the Alliance for Childhood Cancer, and the entire childhood cancer community.
Solving Kids’ Cancer 2018 Spring Celebration
On Wednesday, May 16th, Solving Kids’ Cancer (SKC), an NYC based nonprofit, held its annual Spring Celebration benefit gala at the Mandarin Oriental New York. Mikhail “Doctor Mike” Varshavski served as the Master of Ceremonies of the event, which was hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young and raised over $575,000 for pediatric cancer research.